Financial Reports

ACGT’s complete 990 form is available for your review and information.

CONDENSED STATEMENTS OF ACTIVITIES 2016 2015
Support and revenue:
  Contributions  $950,413  $960,174
  Contributions for administrative expenses (specially designated)  313,443  364,150
  Contributed services  461,802  357,585
  Interest and dividend income  101,788  102,399
  Realized and unrealized gains on investments, net  (362,703)  160,067
  TOTAL SUPPORT AND REVENUE 1,464,743 1,944,375
Expenses:
  Program services:
     Research grants and awards 1,626,508 1,739,756
  Management and general 219,584 225,863
  Fundraising 154,222 103,799
  TOTAL EXPENSES 2,000,314 2,069,418
 (Decrease) increase in total net assets  (535,571)  (125,043)
  Total net assets at beginning of year  3,857,659  3,982,702
TOTAL NET ASSETS AT END OF YEAR $3,322,088 $3,857,659

 

CONDENSED STATEMENTS OF FINANCIAL POSITION 2016 2015
Assets:
   Cash and cash equivalents  $1,259,779  $646,150
   Contributions receivable, net 3,861,376 4,361,280
   Investments, at fair value  10,633  24,523
   Accounts receivable and prepaid expenses
  TOTAL ASSETS $5,131,788 $5,031,953
Liabilities and net assets:
  Liabilities
     Grants payable  $56,401  $35,401
     Accounts payable and accrued expenses  1,753,299  1,139,253
  TOTAL LIABILITIES 1,809,700 1,174,294
  TOTAL NET ASSETS 3,322,088 3,857,659
TOTAL LIABILITIES AND NET ASSETS $5,131,788 $5,031,953

Alliance for Cancer Gene Therapy, Inc.’s complete financial statements are available upon request.